+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 59 Pages
  • October 2021
  • GlobalData
  • ID: 1290793
Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review provides you with an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:


  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights


Misonix Inc (Misonix) is a medical technology company that provides ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery procedures. The company’s product portfolio includes BoneScalpel and BoneScalpel MIS cutting system; SonaStar surgical aspirator; SonicOne wound cleansing and debridement system, TheraSkin real human skin allograft, and Therion dehydrated and terminally sterilized allograft. Its products are used for orthopedic surgery, general surgery, neurosurgery, plastic surgery, maxillofacial surgery and wound care. It has a production facility in Farmingdale, New York, and sells products through direct salespersons and sales agents in the US and through an extensive network of distributors across the world. Misonix is headquartered in New York, the US.

Misonix Inc Key Recent Developments


Sep 02, 2021: Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Aug 02, 2021: Misonix’s proposed merger with Bioventus faces investigation
Jul 29, 2021: Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
May 14, 2021: Misonix Appoints Patrick J. Beyer to Board of Directors
May 06, 2021: Misonix Reports Fiscal 2021 Third Quarter Financial Results

Key benefits of buying this profile include:


You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Misonix Inc - Key Facts
  • Misonix Inc - Key Employees
  • Misonix Inc - Key Employee Biographies
  • Misonix Inc - Major Products and Services
  • Misonix Inc - History
  • Misonix Inc - Company Statement
  • Misonix Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries

Section 2 - Company Analysis
  • Company Overview
  • Misonix Inc - Business Description
  • Business Segment: Surgical
  • Overview
  • Performance
  • Business Segment: Wound Care
  • Overview
  • Performance
  • Geographical Segment: Domestic
  • Performance
  • Geographical Segment: International
  • Performance
  • R&D Overview
  • Misonix Inc - Corporate Strategy
  • Misonix Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Misonix Inc - Strengths
  • Misonix Inc - Weaknesses
  • Misonix Inc - Opportunities
  • Misonix Inc - Threats
  • Misonix Inc - Key Competitors

Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Misonix Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • Misonix Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
  • Sep 02, 2021: Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
  • Aug 02, 2021: Misonix’s proposed merger with Bioventus faces investigation
  • Jul 29, 2021: Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
  • May 14, 2021: Misonix Appoints Patrick J. Beyer to Board of Directors
  • May 06, 2021: Misonix Reports Fiscal 2021 Third Quarter Financial Results
  • Apr 20, 2021: Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6
  • Mar 01, 2021: Misonix to Participate in Upcoming March Investor Conferences
  • Feb 04, 2021: Misonix reports fiscal 2021 second quarter financial results
  • Jan 21, 2021: Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4
  • Oct 06, 2020: Misonix reports preliminary fiscal 2021 first quarter revenue of approximately $17.7 million

Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact the Publisher
  • Disclaimer

List of Tables
  • Misonix Inc, Key Facts
  • Misonix Inc, Key Employees
  • Misonix Inc, Key Employee Biographies
  • Misonix Inc, Major Products and Services
  • Misonix Inc, History
  • Misonix Inc, Subsidiaries
  • Misonix Inc, Key Competitors
  • Misonix Inc, Ratios based on current share price
  • Misonix Inc, Annual Ratios
  • Misonix Inc, Interim Ratios
  • Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Misonix Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
  • Misonix Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios

List of Figures
  • Misonix Inc, Performance Chart (2017 - 2021)
  • Misonix Inc, Ratio Charts
  • Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
  • Misonix Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Synthes Inc
  • MiMedx, Inc.
  • Stryker Corp
  • Integra LifeSciences Holdings Corp
  • Analogic Corp